Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q1 2025 Earnings Call Transcript
Operator: Greetings and welcome to the Collegium Pharmaceutical First Quarter 2025 Earnings Conference Call.
Posts Tagged ‘NASDAQ:COLL’
12 Best Small Cap Pharma Stocks to Buy Now
Emily Field, Head of European Pharma Research at Barclays, spoke on CNBC on February 20 about the performance of obesity medications, the effects of US tariffs, and the dynamics...
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q4 2024 Earnings Call Transcript
Operator: Greetings and welcome to the Collegium Pharmaceuticals Fourth Quarter and Full Year 2024 Earnings Conference Call.
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q3 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the Collegium Pharmaceutical Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q2 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the Collegium Pharmaceutical Second Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
10 Stocks Receiving a Massive Vote of Approval From Wall Street Analysts
The major index futures are slightly in the red this morning.
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q1 2024 Earnings Call Transcript
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q1 2024 Earnings Call Transcript May 9, 2024Collegium Pharmaceutical, Inc. misses on earnings expectations.
5 Best Small Cap Pharma Stocks to Invest In
In this piece, we will take a look at the five best small cap pharma stocks to invest in.
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q4 2023 Earnings Call Transcript
Collegium Pharmaceutical, Inc. misses on earnings expectations. Reported EPS is $0.82 EPS, expectations were $1.33.
13 Best Short Squeeze Stocks To Buy Now
In this piece, we will take a look at the 13 best short squeeze stocks to buy now.
Reasons to Invest in Collegium Pharmaceutical (COLL)
Third Avenue Management, an investment management company based in New York City, released its “Small-Cap Value Fund” fourth quarter 2023 investor letter.
12 Cheap NASDAQ Stocks To Buy
In this piece, we will take a look at the 12 cheap NASDAQ stocks to buy.
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q3 2023 Earnings Call Transcript
Operator: Greetings, and welcome to Collegium Pharmaceuticals Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q2 2023 Earnings Call Transcript
Operator: Greetings. Welcome to the Collegium Pharmaceuticals Second Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
5 Best Small Cap Pharma Stocks to Buy
In this piece, we will take a look at the five best small cap pharma stocks to buy.
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q1 2023 Earnings Call Transcript
Operator: Greetings and welcome to the Collegium Pharmaceutical First Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q4 2022 Earnings Call Transcript
Operator: Greetings, and welcome to the Collegium Pharmaceutical Fourth Quarter and Full Year 2022 Earnings Conference Call.
10 Best Pharmaceutical Stocks to Buy in 2022
In this article, we discuss the 10 best pharmaceutical stocks to buy in 2022.
10 Cheap Pharmaceutical Stocks For 2022
In this article, we discuss 10 cheap pharmaceutical stocks for 2022.
10 Growth Stocks Under $20 in Billionaire Ken Fisher’s Portfolio
In this article, we discuss the 10 growth stocks under $20 in billionaire Ken Fisher's portfolio.
10 Best Biotech Stocks to Buy According to Joseph Edelman’s Perceptive Advisors
In this article, we will discuss the 10 best biotech stocks to buy according to Joseph Edelman’s Perceptive Advisors.
5 Best Pharmaceutical Stocks to Buy According to Billionaire Joseph Edelman
In this article, we discuss the 5 best pharmaceutical stocks to buy according to billionaire Joseph Edelman.
Is COLL A Good Stock To Buy Now?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Collegium Pharmaceutical Inc (COLL): Hedge Funds Taking Some Chips Off The Table
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).
Did Hedge Funds Make The Right Call On Collegium Pharmaceutical Inc (COLL) ?
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).
Hedge Funds Keep Buying Collegium Pharmaceutical Inc (COLL)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
These Hedge Funds Cashed Out Of Collegium Pharmaceutical Inc (COLL) Too Early
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios.
Were Hedge Funds Right About Souring On Collegium Pharmaceutical (COLL)?
Legendary investors such as Jeffrey Talpins and Seth Klarman earn enormous amounts of money for themselves and their investors by doing in-depth research on small-cap stocks that...
Hedge Funds Have Never Been This Bullish On Collegium Pharmaceutical Inc (COLL)
How do we determine whether Collegium Pharmaceutical Inc (NASDAQ:COLL) makes for a good investment at the moment? We analyze the sentiment of a select group of the very best investors...
Were Hedge Funds Right About Dumping Collegium Pharmaceutical Inc (COLL) ?
At Insider Monkey, we pore over the filings of nearly 750 top investment firms every quarter, a process we have now completed for the latest reporting period.
Do Hedge Funds Love Collegium Pharmaceutical Inc (COLL)?
The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers included in our extensive...
Collegium Pharmaceutical, Inc. (NASDAQ:COLL): Are Hedge Funds Right About This Stock?
The 700+ hedge funds and money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the second quarter, which unveil their equity positions...
Is Collegium Pharmaceutical Inc (COLL) A Good Stock To Buy?
The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers included in our extensive...
Why Collegium Pharmaceuticals Inc (COLL), Galmed Pharmaceuticals Ltd (GLMD) and Three Other Stocks Are Registering Significant Gains Today
As the main indices are heading towards ending today's session in the green territory, let's take a look at five stocks that are registering significant gains today.
Icahn Cuts Stake In Gannett Co Inc. (GCI), Sandell Gives Up On Ethan Allen Interiors Inc. (ETH), Plus Two Other Moves
Shareholder activism has been surging over the past several years, with the shareholder activism arena managing approximately $120 billion in assets under management.
Why Are These Five Stocks Sinking Today?
The US stock market is trading slightly in the green territory amid positive news from China and following solid employment figures, but shares of American Eagle Outfitters (NYSE...
3 Healthcare Stocks Making Big Moves Today, Not All Of Them Good Ones
Three healthcare stocks have been very active during both the pre-market and morning trading sessions today. Raptor Pharmaceutical Corp.
